Urinary bone resorption markers (deoxypyridinoline and C-terminal telopeptide of type i collagen) in healthy persons, postmenopausal osteoporosis and patients with type i diabetes

Advances in Medical Sciences

Volumn 54, Issue 1, 2009, Pages 1-6

  Fassbender, W J ^a,f   Godde M ^b   Brandenburg, V M ^c   Usadel, K H ^d   Stumpf, U C ^e  

^a Department of Internal Medicine   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^d Endokrinologikum Frankfurt   (Germany)

^e UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^f HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Biochemical markers of bone metabolism in urine; Carboxyterminal peptide of type I collagen; Chemiluminescence enzyme immunoassay; CTX; Deoxypyridinoline; DPD; ELISA

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; DEOXYPYRIDINOLINE; INSULIN; VITAMIN D; AMINO ACID; BIOLOGICAL MARKER; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; PEPTIDE;

ADULT; AGED; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOASSAY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; POSTMENOPAUSE OSTEOPOROSIS; PROTEIN CONTENT; PROTEIN DETERMINATION; URINALYSIS; URINE LEVEL; BONE DENSITY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; IMMUNOLOGY; MIDDLE AGED; OSTEOLYSIS; PATHOPHYSIOLOGY; REGRESSION ANALYSIS; URINE;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACIDS; BIOLOGICAL MARKERS; BONE DENSITY; BONE RESORPTION; CHEMILUMINESCENT MEASUREMENTS; COLLAGEN TYPE I; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PEPTIDES; REGRESSION ANALYSIS; YOUNG ADULT;

EID: 66149138367     PISSN: 18961126     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10039-009-0003-x     Document Type: Article

References (23)

1. Delmas P. D. Biological markers of bone metabolism. Presse Med. 1993 Feb. 20; 22 (6): 263-8.
2. Risteli L. Risteli J. Biochemical markers of bone metabolism. Ann Med. 1993 Aug; 25 (4): 385-93. (Pubitemid 23250277)
3. Eastell R. Robins S. P. Colwell T. Assiri A. M. Riggs B. L. Russell R. G. Evaluation of bone turnover in type I osteoporosis using biochemical markers specifc for both bone formation and bone resorption. Osteoporos Int. 1993 Sep; 3 (5): 255-60. (Pubitemid 23252444)
4. Souberbielle J. C. Cormier C. Kindermans C. Bone markers in clinical practice. Curr Opin Rheumatol. 1999 Jul; 11 (4): 312-9. (Pubitemid 29383865)
5. Fassbender W. J. Steinhauer B. Stracke H. Schumm-Draeger P. M. Usadel K. H. Validation of a new automated immunoassay for measurement of intact osteocalcin. Clin Lab. 2002; 48 (1-2): 31-8.
6. Lueken S. A. Arnaud S. B. Taylor A. K. Baylink D. J. Changes in markers of bone formation and resorption in a bed rest model of weightlessness. J Bone Miner Res. 1993 Dec; 8 (12): 1433-8. (Pubitemid 23342679)
7. Okabe R. Inaba M. Nakatsuka K. Miki T. Naka H. Moriguchi A. Nishizawa Y. Signifcance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline. J Bone Miner Metab. 2004; 22 (2): 127-31. (Pubitemid 38405041)
8. Seibel M. J. Biochemical markers of bone metabolism in the assessment of osteoporosis: useful or not? J Endocrinol Invest. 2003 May; 26 (5): 464-71. (Pubitemid 36896331)
9. Delmas P. D. Recker R. R. Chesnut C. H. 3rd Skag A. Stakkestad J. A. Emkey R. Gilbride J. Schimmer R. C. Christiansen C. Daily and intermittent oral ibandronate normalize bone turnover and provide signifcant reduction in vertebral fracture risk: results from the BONE study. Osteoporos Int. 2004 Oct; 15 (10): 792-8. (Pubitemid 39361949)
10. Babson A. L. The IMMULITE Automated Immunoassay System. J Clin Immunoassay 1991; 14: 83-8.
11. Catellier D. J. Muller K. E. Tests for gaussian repeated measures with missing data in small samples. Stat Med. 2000 Apr. 30; 19 (8): 1101-14. (Pubitemid 30238918)
12. Siegmund T. Fassbender W. J. [Diabetes mellitus and osteoporosis risk] Dtsch Med Wochenschr. 2003 Apr. 25; 128 (17): 937-40. (Pubitemid 36543178)
13. Iki M. Morita A. Ikeda Y. Sato Y. Akiba T. Matsumoto T. Nishino H. Kagamimori S. Kagawa Y. Yoneshima H. JPOS Study Group. Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women-the Japanese Population-based Osteoporosis (JPOS) Cohort Study. Osteoporos Int. 2006; 17 (7): 1086-95. (Pubitemid 43864861)
14. Garnero P. Shih W. J. Gineyts E. Karpf D. B. Delmas P. D. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab. 1994 Dec; 79 (6): 1693-700.
15. Garnero P. Gineyts E. Arbault P. Christiansen C. Delmas P. D. Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. J Bone Miner Res. 1995 Apr; 10 (4): 641-9.
16. Green J. H. Correlations between biochemical markers of bone resorption and creatinine excretion. Scand J Clin Lab Invest. 2001 Feb; 61 (1): 27-32. (Pubitemid 32240870)
17. Schober E. A. Breusch S. J. Schneider U. Instability and variability of urinary telopeptides and free crosslinks. Clin Chim Acta. 2002 Oct; 324 (1-2): 73-9. (Pubitemid 35245497)
18. Garnero P. Sornay-Rendu E. Duboeuf F. Delmas P. D. Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study. J Bone Miner Res. 1999 Sep; 14 (9): 1614-21. (Pubitemid 29416689)
19. Garnero P. Hausherr E. Chapuy M. C. Marcelli C. Grandjean H. Muller C. Cormier C. Bréart G. Meunier P. J. Delmas P. D. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. J Bone Miner Res. 1996 Oct; 11 (10): 1531-8. (Pubitemid 26331009)
20. van Daele P. L. Seibel M. J. Burger H. Hofman A. Grobbee D. E. van Leeuwen J. P. Birkenhäger J. C. Pols H. A. Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study. BMJ. 1996 Feb. 24; 312 (7029): 482-3. (Pubitemid 26061239)
21. Garnero P. Sornay-Rendu E. Claustrat B. Delmas P. D. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res. 2000 Aug; 15 (8): 1526-36. (Pubitemid 30484522)
22. Bauer D. C. Garnero P. Hochberg M. C. Santora A. Delmas P. Ewing S. K. Black D. M. for the Fracture Intervention Research Group. Pretreatment levels of bone turnover and the antifracture effcacy of alendronate: the fracture intervention trial. J Bone Miner Res. 2006 Feb; 21 (2): 292-9.
23. Lippi G. Brocco G. Salvagno G. L. Montagnana M. Guidi G. C. Schmidt-Gayk H. Infuence of the sample matrix on the stability of beta-CTX at room temperature for 24 and 48 hours. Clin Lab. 2007; 53 (7-8): 455-9. (Pubitemid 47315444)